Lexaria Corp (LXRP) 0.0980 $LXRP
Enertopia Moves into Health & Wellness as It Awaits MMPR Approvals
ACCESSWIRE - Fri Feb 13, 8:00AM CST
WHITEFISH, MT / ACCESSWIRE / February 13, 2015 / Canada's newly implemented Marijuana for Medical Purposes Regulations ("MMPR"
program has experienced a number of delays over the past few months. With a lot of uncertainty surrounding approval timelines, many companies have begun moving into ancillary businesses to diversify risk and enhance long-term shareholder value. Investors may want to keep a close eye on these trends given the potential for near-term revenue.
NTRI: 17.46 (+0.15)
Lexaria Hires National Sales Strategist and Sponsors First Sales Event
ACCESSWIRE - Fri Feb 13, 7:01AM CST
KELOWNA, BC / ACCESSWIRE / February 13, 2015 / Lexaria Corp. (LXRP) (CSE:LXX) (the "Company" announces that ViPova(TM) by Lexaria is sponsoring its first major sales event; and also announces the hiring of a National Sales Strategist.
5 Canadian Marijuana Stocks With Recommended Entry Prices
Anthony Cataldo - at Seeking Alpha - Tue Feb 10, 1:33AM CST
A Preliminary Examination Of N=35 Canadian Marijuana Stocks... Eh?
Anthony Cataldo - at Seeking Alpha - Mon Feb 09, 3:20AM CST
Lexaria Updates Operations
ACCESSWIRE - Wed Feb 04, 7:35AM CST
KELOWNA, BC / ACCESSWIRE / February 4, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the "Company" provides the following three operational updates.
Lexaria Maintains OTCQB Marketplace Status
Newsfile Corp - Mon Feb 02, 12:27PM CST
full story)
Will Strong U.S. Dollar Lead To Canadian/U.S. Marijuana Firm Mergers?
Anthony Cataldo - at Seeking Alpha - Tue Jan 27, 9:36AM CST
CannabisFN: What to Watch in the Week Ahead
ACCESSWIRE - Tue Jan 20, 1:00PM CST
WHITEFISH, MT / ACCESSWIRE / January 20, 2015 / The cannabis industry began the new year on a high note, with the Marijuana Index(TM) rebounding off of its 52-week lows established on December 31, 2014. With Peter Thiel's big decision to invest in the pot industry and favorable new legislation being introduced, investors' appetite for marijuana stocks could be on the rise in 2015 after a rough end to 2014. The venture market for weed stocks has also been on the rise, which suggests that some big-name initial public offerings could be on the way as the industry matures.
MGW.VN: 0.040 (+0.005)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VI
Anthony Cataldo - at Seeking Alpha - Fri Jan 16, 1:21PM CST
INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
Lexaria Announces ViPova(TM) Website for CBD Research and Direct Tea Sales
Newsfile Corp - Thu Jan 15, 8:46AM CST
full story)
Lexaria Commissions Cannabinoid Education Series
Newsfile Corp - Thu Jan 08, 7:01AM CST
full story)
Canada's Marijuana Market: The Good, Bad, And Ugly
Matthew Finston - at Seeking Alpha - Wed Dec 31, 8:55AM CST
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015
ACCESSWIRE - Tue Dec 30, 9:01AM CST
WHITEFISH, MT / ACCESSWIRE / December 30, 2014 / The rapid expansion of the cannabis industry has offered patients throughout the U.S. a ray of hope when it comes to treating a variety of conditions that medical marijuana (MMJ) is increasingly understood to be effective for. However, exorbitant costs for MMJ patients, associated with registration fees and other price pressures put on producers and distributors, have made MMJ treatments inaccessible to a sizeable portion of the market. This is why Novus Acquisition & Development Corp. (OTC: NDEV), created their innovative Novus MedPlan program, which offers MMJ patients a considerable discount on medicinals, as well as holistic and alternative medicines, using an exclusive provider network cost-savings model to grant members direct and easy access to the nearest providers in their state.
JNJ: 99.62 (+1.18), INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70)
Enertopia Moves into Health & Wellness as It Awaits MMPR Approvals
ACCESSWIRE - Fri Feb 13, 8:00AM CST
WHITEFISH, MT / ACCESSWIRE / February 13, 2015 / Canada's newly implemented Marijuana for Medical Purposes Regulations ("MMPR"
program has experienced a number of delays over the past few months. With a lot of uncertainty surrounding approval timelines, many companies have begun moving into ancillary businesses to diversify risk and enhance long-term shareholder value. Investors may want to keep a close eye on these trends given the potential for near-term revenue. NTRI: 17.46 (+0.15)
Lexaria Hires National Sales Strategist and Sponsors First Sales Event
ACCESSWIRE - Fri Feb 13, 7:01AM CST
KELOWNA, BC / ACCESSWIRE / February 13, 2015 / Lexaria Corp. (LXRP) (CSE:LXX) (the "Company"
announces that ViPova(TM) by Lexaria is sponsoring its first major sales event; and also announces the hiring of a National Sales Strategist. 5 Canadian Marijuana Stocks With Recommended Entry Prices
Anthony Cataldo - at Seeking Alpha - Tue Feb 10, 1:33AM CST
A Preliminary Examination Of N=35 Canadian Marijuana Stocks... Eh?
Anthony Cataldo - at Seeking Alpha - Mon Feb 09, 3:20AM CST
Lexaria Updates Operations
ACCESSWIRE - Wed Feb 04, 7:35AM CST
KELOWNA, BC / ACCESSWIRE / February 4, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the "Company"
provides the following three operational updates. Lexaria Maintains OTCQB Marketplace Status
Newsfile Corp - Mon Feb 02, 12:27PM CST
full story)
Will Strong U.S. Dollar Lead To Canadian/U.S. Marijuana Firm Mergers?
Anthony Cataldo - at Seeking Alpha - Tue Jan 27, 9:36AM CST
CannabisFN: What to Watch in the Week Ahead
ACCESSWIRE - Tue Jan 20, 1:00PM CST
WHITEFISH, MT / ACCESSWIRE / January 20, 2015 / The cannabis industry began the new year on a high note, with the Marijuana Index(TM) rebounding off of its 52-week lows established on December 31, 2014. With Peter Thiel's big decision to invest in the pot industry and favorable new legislation being introduced, investors' appetite for marijuana stocks could be on the rise in 2015 after a rough end to 2014. The venture market for weed stocks has also been on the rise, which suggests that some big-name initial public offerings could be on the way as the industry matures.
MGW.VN: 0.040 (+0.005)
12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VI
Anthony Cataldo - at Seeking Alpha - Fri Jan 16, 1:21PM CST
INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70), FULL: 4.40 (+0.06)
Lexaria Announces ViPova(TM) Website for CBD Research and Direct Tea Sales
Newsfile Corp - Thu Jan 15, 8:46AM CST
full story)
Lexaria Commissions Cannabinoid Education Series
Newsfile Corp - Thu Jan 08, 7:01AM CST
full story)
Canada's Marijuana Market: The Good, Bad, And Ugly
Matthew Finston - at Seeking Alpha - Wed Dec 31, 8:55AM CST
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015
ACCESSWIRE - Tue Dec 30, 9:01AM CST
WHITEFISH, MT / ACCESSWIRE / December 30, 2014 / The rapid expansion of the cannabis industry has offered patients throughout the U.S. a ray of hope when it comes to treating a variety of conditions that medical marijuana (MMJ) is increasingly understood to be effective for. However, exorbitant costs for MMJ patients, associated with registration fees and other price pressures put on producers and distributors, have made MMJ treatments inaccessible to a sizeable portion of the market. This is why Novus Acquisition & Development Corp. (OTC: NDEV), created their innovative Novus MedPlan program, which offers MMJ patients a considerable discount on medicinals, as well as holistic and alternative medicines, using an exclusive provider network cost-savings model to grant members direct and easy access to the nearest providers in their state.
JNJ: 99.62 (+1.18), INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70)
